Previous close | 2.3200 |
Open | 2.3300 |
Bid | 2.3200 x 2100 |
Ask | 2.3500 x 2200 |
Day's range | 2.3250 - 2.4899 |
52-week range | 0.5000 - 3.2200 |
Volume | |
Avg. volume | 2,256,570 |
Market cap | 351.77M |
Beta (5Y monthly) | 1.71 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With the business potentially at an important milestone, we thought we'd take a closer look at Heron Therapeutics...
Heron Therapeutics ( NASDAQ:HRTX ) Full Year 2023 Results Key Financial Results Revenue: US$127.0m (up 18% from FY...